Evidence map›Paper›PMID 33523371›Full record

Observational studyMolecular biology reports2021

Epidemiological surveillance of chikungunya fever in Mexico since its introduction in 2014-2016 and identification of circulating genotypes.

Belem Torres-Longoria, David Esaú Fragoso-Fonseca, Alma Núñez-León, María de la Luz Torres, Mauricio Vázquez-Pichardo, Noé Escobar-Escamilla, Claudia Wong-Arámbula, José Ernesto Ramírez-González, Alfonso Méndez-Tenorio, María Eugenia Castro-Mussot and 4 more

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Molecular biology reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Belem Torres-LongoriaLaboratorio de Inmunorregulación, Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico.
David Esaú Fragoso-FonsecaUnidad de Desarrollo Tecnológico e Investigación Molecular, Instituto de Diagnóstico y Referencia Epidemiológicos "Dr, Manuel Martínez Báez" (InDRE), Secretaria de Salud, Mexico City, Mexico.ORCID http://orcid.org/0000-0002-7344-7757
Alma Núñez-LeónDepartamento de Virología, Instituto de Diagnóstico y Referencia Epidemiológicos "Dr. Manuel Martínez Báez" (InDRE), Secretaria de Salud, Mexico City, Mexico.
María de la Luz TorresDepartamento de Virología, Instituto de Diagnóstico y Referencia Epidemiológicos "Dr. Manuel Martínez Báez" (InDRE), Secretaria de Salud, Mexico City, Mexico.
Mauricio Vázquez-PichardoDepartamento de Virología, Instituto de Diagnóstico y Referencia Epidemiológicos "Dr. Manuel Martínez Báez" (InDRE), Secretaria de Salud, Mexico City, Mexico.
Noé Escobar-EscamillaUnidad de Desarrollo Tecnológico e Investigación Molecular, Instituto de Diagnóstico y Referencia Epidemiológicos "Dr, Manuel Martínez Báez" (InDRE), Secretaria de Salud, Mexico City, Mexico.ORCID http://orcid.org/0000-0001-8929-476X
Claudia Wong-ArámbulaUnidad de Desarrollo Tecnológico e Investigación Molecular, Instituto de Diagnóstico y Referencia Epidemiológicos "Dr, Manuel Martínez Báez" (InDRE), Secretaria de Salud, Mexico City, Mexico.
José Ernesto Ramírez-GonzálezUnidad de Desarrollo Tecnológico e Investigación Molecular, Instituto de Diagnóstico y Referencia Epidemiológicos "Dr, Manuel Martínez Báez" (InDRE), Secretaria de Salud, Mexico City, Mexico.ORCID http://orcid.org/0000-0003-0477-2211
Alfonso Méndez-TenorioLaboratorio Biotecnología y Bioinformática Genómica, Departamento de Bioquímica, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Universidad Nacional Autónoma de México, Mexico City, Mexico.
María Eugenia Castro-MussotLaboratorio de Inmunología Celular e Inmunopatogénesis, Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico.
María M B Moreno-AltamiranoLaboratorio de Inmunorregulación, Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico.
Jorge Membrillo-HernándezEscuela de Ingeniería y Ciencias, Tecnológico de Monterrey, Mexico City, Mexico.ORCID http://orcid.org/0000-0001-7650-8116
Irma López-MartínezUnidad de Desarrollo Tecnológico e Investigación Molecular, Instituto de Diagnóstico y Referencia Epidemiológicos "Dr, Manuel Martínez Báez" (InDRE), Secretaria de Salud, Mexico City, Mexico.
José Alberto Díaz-QuiñónezDivisión de Estudios de Posgrado, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City, Mexico. adiazq@unam.mx.ORCID http://orcid.org/0000-0002-3503-7079

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In 2014, the chikungunya virus (CHIKV) was detected for the first time in Mexico, the identified strain was the one corresponding to the Asian genotype which was phylogenetically grouped with the strains that circulated in the British Virgin Islands outbreak and was later classified with lineages of Caribbean strains. In three years, 13,569 cases of chikungunya were registered in Mexico. Although the transmission and spread of the virus are now considered a moderate risk, the danger that the virus reemerges is not ruled out due to the infestation of Aedes mosquitoes. In this study, we reviewed the chikungunya fever (CHIKF) cases reported between 2014 and 2016 to reanalyze the data. Seventeen cases were selected from different states where the circulation of the virus had been reported. Statistical data were analyzed and a retrospective analysis was carried out. Nucleic acid sequences were determined of these 17 samples. 2015 was the year with the highest number of cases (92.8%) and they were detected in 28 states of the country. There is a predominance of females, and the most affected age group was between 25 and 44 years. In 2016, CHIKV genotypes were not known, in this study the presence of the Asian genotype of Caribbean lineage was confirmed. The presence of the West African and ECSA genotypes was phylogenetically ruled out. The sequences obtained were deposited in GeneBank.

Indexed as

AdolescentAdultChikungunya FeverChikungunya virusChildChild, PreschoolDatabases, GeneticDisease OutbreaksFemaleGenotypeHumansMaleMexicoMiddle AgedPhylogenyRetrospective StudiesCHIKFCHIKVGenotypeNext generation sequencingPhylogeny

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.